Evidence map›Paper›PMID 26133384›Full record

ArticleMolecular biology of the cell2015

Proteomic identification of novel cytoskeletal proteins associated with TbPLK, an essential regulator of cell morphogenesis in Trypanosoma brucei.

Michael R McAllaster, Kyojiro N Ikeda, Ana Lozano-Núñez, Dorothea Anrather, Verena Unterwurzacher, Thomas Gossenreiter, Jenna A Perry, Robbie Crickley, Courtney J Mercadante, Sue Vaughan and 1 more

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Michael R McAllasterDepartment of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912.
Kyojiro N IkedaMax F. Perutz Laboratories, Department of Medical Biochemistry, Medical University of Vienna, 1030 Vienna, Austria.
Ana Lozano-NúñezMax F. Perutz Laboratories, Center for Molecular Biology, University of Vienna, 1030 Vienna, Austria.
Dorothea AnratherMax F. Perutz Laboratories, Mass Spectrometry Facility, University of Vienna, 1030 Vienna, Austria.
Verena UnterwurzacherMax F. Perutz Laboratories, Mass Spectrometry Facility, University of Vienna, 1030 Vienna, Austria.
Thomas GossenreiterMax F. Perutz Laboratories, Mass Spectrometry Facility, University of Vienna, 1030 Vienna, Austria.
Jenna A PerryDepartment of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912.
Robbie CrickleyDepartment of Biological and Medical Sciences, Faculty of Health and Life Science, Oxford Brookes University, Oxford OX3 0BP, United Kingdom.
Courtney J MercadanteDepartment of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912.
Sue VaughanDepartment of Biological and Medical Sciences, Faculty of Health and Life Science, Oxford Brookes University, Oxford OX3 0BP, United Kingdom.
Christopher L de GraffenriedDepartment of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912 Christopher_deGraffenried@Brown.edu.
Brown University · USUniversity of Vienna · ATOxford Brookes University · GBMax Perutz Labs · AT

Funding

Statistics and Data Management P20GM104317 · NIGMS · UNIVERSITY OF RHODE ISLAND · PI MICHELOW, IAN · 2013 to 2017
$9.8M
The role of polo-like kinase in the duplication of the trypanosome cytoskeletonR01AI112953 · NIAID · BROWN UNIVERSITY · PI DE GRAFFENRIED, CHRISTOPHER LUIS · 2015 to 2019
$2.0M
NIAID NIH HHS R01 AI112953NIAID NIH HHS R01AI112953NIGMS NIH HHS P20 GM104317
6 · The paper itself

Abstract

Trypanosoma brucei is the causative agent of African sleeping sickness, a devastating disease endemic to sub-Saharan Africa with few effective treatment options. The parasite is highly polarized, including a single flagellum that is nucleated at the posterior of the cell and adhered along the cell surface. These features are essential and must be transmitted to the daughter cells during division. Recently we identified the T. brucei homologue of polo-like kinase (TbPLK) as an essential morphogenic regulator. In the present work, we conduct proteomic screens to identify potential TbPLK binding partners and substrates to better understand the molecular mechanisms of kinase function. These screens identify a cohort of proteins, most of which are completely uncharacterized, which localize to key cytoskeletal organelles involved in establishing cell morphology, including the flagella connector, flagellum attachment zone, and bilobe structure. Depletion of these proteins causes substantial changes in cell division, including mispositioning of the kinetoplast, loss of flagellar connection, and prevention of cytokinesis. The proteins identified in these screens provide the foundation for establishing the molecular networks through which TbPLK directs cell morphogenesis in T. brucei.

Indexed as

AnimalsCell Cycle ProteinsCell DivisionCells, CulturedCytokinesisCytoskeletal ProteinsFlagellaMorphogenesisPhosphorylationPolo-Like Kinase 1Protein BindingProtein Serine-Threonine KinasesProteomicsProto-Oncogene ProteinsProtozoan ProteinsTrypanosoma brucei bruceiCell Cycle ProteinsCytoskeletal ProteinsPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene ProteinsProtozoan Proteins

Identifiers

PMID26133384
PMCPMC4551316
OpenAlexW2135772180

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.